Lower rate of palbociclib discontinuation in early HR+ BC patients with higher BMIAugust 17, 2023Breast Cancer
Meta-analysis shows low toxicity incidences with trastuzumab deruxtecan in BCAugust 17, 2023Breast Cancer
Pyrotinib shows promising efficacy and safety in HER+ advanced BC in the real-worldAugust 17, 2023Breast Cancer
Adjuvant chemotherapy non-inferior to neoadjuvant chemotherapy in clinically node-negative T1 TNBCAugust 17, 2023Breast Cancer
Axillary surgery not always indicated in BC patients with 1-2 positive sentinel lymph nodes undergoing mastectomyAugust 17, 2023Breast Cancer
Concomitant use of proton pump inhibitors with palbociclib may affect survival outcomes in breast cancerAugust 17, 2023Breast Cancer
ER+ BC patients discontinuing hormone therapy tend to discontinue cardiovascular therapyAugust 17, 2023Breast Cancer
Breast cancer diagnosis within 5 years of childbirth associated with poor prognosisAugust 17, 2023Breast Cancer
Presence of lobular carcinoma in situ associated with improved prognosis in invasive lobular carcinoma of the breastAugust 17, 2023Breast Cancer
The unique approach involved in age-specific concerns surrounding young patients with breast cancerAugust 2, 2023Breast Cancer
Commentary: Meningioma, Radiotherapy Interruptions, Therapy Persistence, and Lymphocytes in BC, August 2023July 26, 2023Breast Cancer
